In This Section
Charles Swanton, MD, PhD

Charles Swanton, MD, PhD

University College London Cancer Institute
London, United Kingdom

Class of 2020

For his innovative research focused on identifying molecular mechanisms of cancer evolution and its impact on drug resistance and patient stratification and for demonstrating the crucial biological connection between intratumor heterogeneity and clinical cancer biomarker efficacy.